January 27, 2021
Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders
Read MoreOctober 20, 2020
Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer
Read MoreMarch 20, 2020
Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders
Read More